Published in Physician Law Weekly, May 9th, 2007
Under terms of the agreement, Viragen received approximately $2 million ('1.5 million) as an up-front license fee and will serve as the sole manufacturer of the product. Swedish Orphan International will pay Viragen for Multiferon(R) at an agreed upon sales price, and, in addition,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly